Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CHKA | P35790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29388199 | 1.00 | TSHR (0.41) | TSHRKDM4EPKMAPOBEC3AAPOBEC3G | |
| Water SCHEMBL15375414 | 0.98 | TSHR (0.39) | TSHRKDM4EPKMAPOBEC3AAPOBEC3G | |
| Sulfuric Acid SCHEMBL29203158 | 0.93 | KDM4E (0.38) | TSHRKDM4EPKMAPOBEC3AAPOBEC3G | |
| Sulfuric Acid SCHEMBL29203159 | 0.91 | KDM4E (0.37) | TSHRKDM4EPKMAPOBEC3AAPOBEC3G | |
| SCHEMBL15915666 | 0.84 | TDP1 (0.45) | KDM4EPKMAPOBEC3AAPOBEC3GLMNA | |
| SCHEMBL29724065 | 0.84 | TDP1 (0.45) | KDM4EPKMAPOBEC3AAPOBEC3GLMNA | |
| SCHEMBL193561 | 0.83 | GGPS1 (0.34) | KDM4ELMNAGGPS1 | |
| SCHEMBL29388369 | 0.83 | GGPS1 (0.34) | KDM4ELMNAGGPS1 | |
| SCHEMBL514918 | 0.83 | TP53 (0.50) | KDM4EPKMAPOBEC3AAPOBEC3GLMNA | |
| SCHEMBL21490429 | 0.83 | TSHR (0.44) | TSHRKDM4ELMNANPSR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4470972-A1 | PROCESS FOR PRODUCING ONIUM SALTS OF BIS(FLUOROSULFONYL)IMIDE | SPECIALTY OPERATIONS FRANCE (FR) | 2024-12-04 | — | — | EP | claimed |
| CN-119059497-A | Process for the production of onium salts of bis (fluorosulfonyl) imide | 法国特种经营公司 | 2024-12-03 | — | — | CN | claimed |
| CN-114262917-A | Electrolytic nickel (alloy) plating solution | 日本高纯度化学株式会社 | 2022-04-01 | — | — | CN | claimed |
| US-20190330753-A1 | NICKEL (ALLOY) ELECTROPLATING SOLUTION | JAPAN PURE CHEMICAL CO., LTD. (JP) | 2019-10-31 | — | — | US | claimed |
| US-8492538-B1 | Cyclodextrin derivative salts | MATOS JOSE R (US) | 2013-07-23 | — | — | US | claimed |
| EP-2276917-B1 | DEVICE, SYSTEM AND METHOD FOR PROVIDING A REDUCING AGENT FOR A SYSTEM FOR THE SELECTIVE CATALYTIC REDUCTION OF NITROGEN OXIDES | BOSCH GMBH ROBERT (DE) | 2012-03-14 | — | — | EP | claimed |
| EP-2276917-A2 | DEVICE, SYSTEM AND METHOD FOR PROVIDING A REDUCING AGENT FOR A SYSTEM FOR THE SELECTIVE CATALYTIC REDUCTION OF NITROGEN OXIDES | Robert Bosch GmbH (DE) | 2011-01-26 | — | — | EP | claimed |
| WO-2009138296-A2 | DEVICE, SYSTEM AND METHOD FOR PROVIDING A REDUCING AGENT FOR A SYSTEM FOR THE SELECTIVE CATALYTIC REDUCTION OF NITROGEN OXIDES | ROBERT BOSCH GMBH (DE) | 2009-11-19 | — | — | WO | claimed |
| EP-1971666-A1 | PROCESS FOR THE SYNTHESIS OF NANOCRYSTALLINE PHOSPHOR PARTICLES AND NANOCRYSTALLINE PHOSPHOR PARTICLES OBTAINABLE BY THIS PROCESS | UNIVERSITÄT KARLSRUHE (DE) | 2008-09-24 | — | — | EP | claimed |
| WO-2007082663-A1 | PROCESS FOR THE SYNTHESIS OF NANOCRYSTALLINE PHOSPHOR PARTICLES AND NANOCRYSTALLINE PHOSPHOR PARTICLES OBTAINABLE BY THIS PROCESS | UNIVERSITÄT KARLSRUHE (DE) | 2007-07-26 | — | — | WO | claimed |
| US-20260118757-A1 | RADIATION-SENSITIVE RESIST COMPOSITION AND PATTERN FORMATION METHOD USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-04-30 | — | — | US | disclosed |
| US-20250129487-A1 | PRODUCTION METHOD FOR AMMONIA AND PRODUCTION DEVICE | NISSAN CHEMICAL CORPORATION (JP) | 2025-04-24 | — | — | US | disclosed |
| EP-4470972-A1 | PROCESS FOR PRODUCING ONIUM SALTS OF BIS(FLUOROSULFONYL)IMIDE | SPECIALTY OPERATIONS FRANCE (FR) | 2024-12-04 | — | — | EP | disclosed |
| CN-119059497-A | Process for the production of onium salts of bis (fluorosulfonyl) imide | 法国特种经营公司 | 2024-12-03 | — | — | CN | disclosed |
| US-20240383752-A1 | REACTIVE DISTILLATION PROCESS FOR PREPARING FLUOROSULFONYLIMIDE SALTS | SPECIALTY OPERATIONS FRANCE (FR) | 2024-11-21 | — | — | US | disclosed |
| EP-0693708-A1 | Silver halide photographic element and process for the formation of high contrast negative images | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-01-24 | — | — | EP | disclosed |
| US-5130480-A | In silver halide elements; images with ultrahigh contrast; reprography, photo typesetting, photomasks | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-07-14 | — | — | US | disclosed |
| US-5013844-A | Photographic emulsions, high contrast | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-05-07 | — | — | US | disclosed |
| US-4937160-A | High contrast | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-06-26 | — | — | US | disclosed |
| EP-0356898-A2 | Silver halide photographic materials containing aryl hydrazides | DU PONT DE NEMOURS (DEUTSCHLAND) GMBH (DE) | 1990-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260118757-A1 | RADIATION-SENSITIVE RESIST COMPOSITION AND PATTERN FORMATION METHOD USING THE SAME | SLC39A14, HCN4, SLC11A2 | TSHR 897/4885KDM4E 2974/4885PKM 1215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.